Data Sources: PubMed, Google Scholar, Clinical Pharmacology
Data synthesis: There are studies that evaluate the use of antidepressants in heart failure patients resulting in all-cause mortality and hospitalizations.
Conclusions: The use of antidepressants in patients with heart failure can lead to many cardiovascular adverse effects. When use is warranted and necessary, the safest class of antidepressants to use is an SSRI.
Request: Should we be using antidepressants in patients with heart failure?
Background:
Heart Failure is a multifaceted clinical syndrome which results from either functional or structural impairment of ventricular filling or ejection of …show more content…
D.I. Mann, M.R. Bristow, Mechanisms and models in heart failure: the biomechanical model and beyond, Circulation 111 (2005) 2837-2849.
3. W.F. Stewart, J.A. Ricci, E. Chee, et al., Cost of lost productive work time among US workers with depression, JAMA 289 (2003) 3135-3144
4. M. Daskalopoulou, J. George, K. Walters, et al., Depression as a risk factor for initial presentation of twelve cardiac, serebrovascular, and peripheral arterial diseases: data linkage study of 1.9 million women and men, PLoS One 11 (2016), e0153838.
5. K. Watson, K.M. Summers, Depression in patients with heart failure: clinical implications and management, Pharmacotherapy 29 (2009) 49-63.
6. E.I. Fosbol, G.H. Gislason, H.E. Poulsen, et al., Prognosis in heart failure: clinical implications and management, pharmacotherapy 29 (2009) …show more content…
K.T. Veien, L. Videbaek, M. Shou, et al., High mortality among heart failure patients treated with antidepressants, Int. J. Cardio. 146 (2011) 64-67.
8. S.P. Roose, M. Miyazaki, Pharmacologic treatment of depression in patients with heart disease. Psychosom. Med. 67 (Suppl. 1) 2005) S54-S57.
9. K. Jolly, M.D. Gammage, K.K. Cheng, et al., Sudden death in patients receiving drugs tending to prolong the QT interval, Br. J. Clin. Pharmacol. 68 (5) (2009) 743-751.
10. R. Ghosh, S. Ball, V. Prasad, A. Gupta, Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interactions from recent clinical studies, International Journal of Cardiology 224 (2016) 170-177.
11. G.I. Xiong, M. Fiuzat, M. Kuchibhatla, et al, SADHART-CHF Investigators, Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHARTCHF trial, Circ. Heart Fail. 5 (2012) 688-692.
12. C.E. Angermann. G. Gelbrinch, S/ Stork, et al. MOOD-HF Study Investigators and Committee Members, Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomization clinical trial, JAMA 315 (2016)